SCHEMBL8989243

SCHEMBL8989243

COc1ccc(-c2nc(C=O)c(C)n2C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.44
ALDH1A1 P00352 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
LMNA P02545 1/20 0.42
BACE1 P56817 1/20 0.42
CYP2A6 P11509 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
PKM P14618 1/20 0.41
MDM2 Q00987 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PTGS1 P23219 3/20 0.41
PTGS2 P35354 3/20 0.41
NLRP3 Q96P20 1/20 0.41
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18003544 0.81 ALOX5 (0.42) ALDH1A1KDM4EMAPTKDM4CLMNA
SCHEMBL18003191 0.81 ALDH1A1 (0.54) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL8989194 0.80 ADORA2B (0.44) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL23444495 0.78 MEN1 (0.50) PARP1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL8989143 0.73 PPARG (0.47) PARP1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL1544992 0.73 ALDH1A1 (0.47) PARP1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL5418012 0.73 PTGS2 (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28536742 0.72 MAPT (0.50) PARP1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL22494221 0.70 RAB9A (0.62) ALDH1A1NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL28277279 0.69 KDM4E (0.66) PARP1ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed